Cystic Fibrosis Canada’s position on cannabis in the treatment of cystic fibrosis
TORONTO (October 17, 2018) – Cannabis (also referred to as marijuana) has been available by prescription for a number of years in Canada, but with broader legalization, more interest has been raised on the subject.
For purposes of the treatment of cystic fibrosis, it is acknowledged that many individuals use alternative or complementary therapies that fall outside of their medication and treatment regimens prescribed by the healthcare professionals at their CF clinics. This is an individual choice, and one that should be discussed openly with their CF clinic teams.
There is very little conclusive research on the role and effects of cannabis and how it affects the disease state; however, Cystic Fibrosis Canada’s Healthcare Advisory Council agrees that, should individuals with cystic fibrosis choose to use cannabis in their personal treatment regimens, it is recommended that, of the various delivery modalities available, it should not be smoked, vaporized or inhaled in any way. Further, second-hand cannabis smoke is to be avoided.
As always, it is recommended that individuals consult with their CF clinics regarding all medications and treatments they use, to reduce the risk of negative or adverse effects.
For additional information on the use of cannabis, please visit the Government of Canada’s website, here.
For more information, contact:
Jennifer Stranges, Associate, Corporate Communications
Cystic Fibrosis Canada
Tel: 416-485-9149 ext. 290
Tel: 1-800-378-2233 ext. 290
Back to Listing